Drug discovery company Selvita establishes UK subsidiary in Cambridge
5 May 2015 | By Victoria White
Selvita, a global drug discovery company with offices in the US and Poland, is opening its first office in the UK in Cambridge...
List view / Grid view
News
Kallistem announces a world first: human spermatogenesis in vitro
5 May 2015 | By Victoria White
Kallistem has produced a fully formed human spermatozoa in the laboratory setting, using patient testicular biopsies containing only immature germ cells...
Shire and Foundation Fighting Blindness announce new adRP research agreement
5 May 2015 | By Victoria White
Shire and the Foundation Fighting Blindness have entered in to an agreement focused on furthering research for a novel treatment for adRP...
The Michael J. Fox Foundation and Prothena partner to accelerate discovery of novel biomarkers for Parkinson’s disease
5 May 2015 | By Victoria White
MJFF and Prothena have teamed up to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson's disease progression...
ReNeuron gets approval to start a Phase I/II clinical trial in the US in retinitis pigmentosa
5 May 2015 | By Victoria White
ReNeuron has received approval from the FDA to commence a Phase I/II clinical trial in the US with its hRPC therapy candidate for retinitis pigmentosa...
Scientists identify key receptors behind development of acute myeloid leukaemia
30 April 2015 | By Victoria White
Researchers have found that ITIM - receptors are important to the development of acute myeloid leukaemia (AML), providing a target for potential therapies...
New method of investigating human lung tissue enables improved drug target validation for COPD treatment
30 April 2015 | By Victoria White
Scientists at Helmholtz Zentrum München have succeeded in testing the effectiveness of new approaches for treating COPD on ex vivo 3D-LTCs...
NIH to fund $10.5 million multi-site, interdisciplinary research effort to investigate the role of non-inherited genetic mutations in schizophrenia
30 April 2015 | By Victoria White
NIH funded project to identify the causes of schizophrenia and other neurodevelopmental disorders to guide development of more effective treatments...
Biotech companies present novel approaches to fight infections at ECCMID’s pipeline corner
30 April 2015 | By Victoria White
Biotech companies presented new mechanisms and approaches in the global fight against infections in a pipeline session at ECCMID...
Genetic mutation could protect against development of Type 2 diabetes
29 April 2015 | By Victoria White
An international team of scientists has identified a new genetic mutation that appears to protect people from developing Type 2 diabetes...
New study explores memory-rescuing potential of inhibiting HDACs
29 April 2015 | By Victoria White
Inhibiting HDACs has shown significant potential in stimulating the growth of brain cells and memory restoration in animal models that mimic Alzheimer’s...
Discovery of an unexpected function of the protein dDsk2
28 April 2015 | By Victoria White
A new function now described for the protein dDsk2 links ubiquitin receptors for the first time with the regulation of gene expression...
New therapeutic target for colorectal cancer has been identified
28 April 2015 | By Victoria White
Researchers at the Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer...
New signalling pathway discovered in HER2-positive breast cancer
28 April 2015 | By Victoria White
A team at CSHL has published results of experiments that lay bare a previously unknown pathway activated in HER2-positive breast cancer...
4DMT and Roche sign collaboration agreement for gene therapy vector discovery and product development
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...